Pawel Leznicki

Pawel Leznicki

Auto-generated profile, based on publicly available information

Pawel Leznicki

Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
PLPawel Leznicki
Pawel Leznicki
ACAnne Clancy
Anne Clancy
BSBlanche Schwappach
Blanche Schwappach
SHStephen High
Stephen High
The membrane integration of tail-anchored proteins at the endoplasmic reticulum (ER) is post-translational, with different tail-anchored proteins exploiting distinct cytosolic factors. For example, mammalian TRC40 has a well-defined role during delivery of tail-anchored proteins to the ER. Although its Saccharomyces cerevisiae equivalent, Get3, is known to function in concert with at least four other components, Get1, Get2, Get4 and Get5 (Mdy2), the role of additional mammalian proteins during tail-anchored protein biogenesis is unclear. To this end, we analysed the cytosolic binding partners of Sec61β, a well-defined substrate of TRC40, and identified Bat3 as a previously unknown interacting partner. Depletion of Bat3 inhibits the membrane integration of Sec61β, but not of a second, TRC40-independent, tail-anchored protein, cytochrome b5. Thus, Bat3 influences the in vitro membrane integration of tail-anchored proteins using the TRC40 pathway. When expressed in Saccharomyces cerevisiae lacking a functional GET pathway for tail-anchored protein biogenesis, Bat3 associates with the resulting cytosolic pool of non-targeted chains and diverts it to the nucleus. This Bat3-mediated mislocalisation is not dependent upon Sgt2, a recently identified component of the yeast GET pathway, and we propose that Bat3 either modulates the TRC40 pathway in higher eukaryotes or provides an alternative fate for newly synthesised tail-anchored proteins.

15 May 2007 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
BABenjamin M. Abell
Benjamin M. Abell
CRCatherine Rabu
Catherine Rabu
PLPawel Leznicki
Pawel Leznicki
JYJason C. Young
Jason C. Young
SHStephen High
Stephen High
Tail-anchored (TA) proteins provide an ideal model for studying post-translational integration at the endoplasmic reticulum (ER) of eukaryotes. There are multiple pathways for delivering TA proteins from the cytosol to the ER membrane yet, whereas an ATP-dependent route predominates, none of the cytosolic components involved had been identified. In this study we have directly addressed this issue and identify novel interactions between a model TA protein and the two cytosolic chaperones Hsp40 and Hsc70. To investigate their function, we have reconstituted the membrane integration of TA proteins using purified components. Remarkably, we find that a combination of Hsc70 and Hsp40 can completely substitute for the ATP-dependent factors present in cytosol. On the basis of this in vitro analysis, we conclude that this chaperone pair can efficiently facilitate the ATP-dependent integration of TA proteins.

15 June 2017 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
PLPawel Leznicki
Pawel Leznicki
YKYogesh Kulathu
Yogesh Kulathu
Deubiquitylating (or deubiquitinating) enzymes (DUBs) are proteases that reverse protein ubiquitylation and therefore modulate the outcome of this post-translational modification. DUBs regulate a variety of intracellular processes, including protein turnover, signalling pathways and the DNA damage response. They have also been linked to a number of human diseases, such as cancer, and inflammatory and neurodegenerative disorders. Although we are beginning to better appreciate the role of DUBs in basic cell biology and their importance for human health, there are still many unknowns. Central among these is the conundrum of how the small number of ∼100 DUBs encoded in the human genome is capable of regulating the thousands of ubiquitin modification sites detected in human cells. This Commentary addresses the biological mechanisms employed to modulate and expand the functions of DUBs, and sets directions for future research aimed at elucidating the details of these fascinating processes. This article is part of a Minifocus on Ubiquitin Regulation and Function. For further reading, please see related articles: ‘Exploitation of the host cell ubiquitin machinery by microbial effector proteins’ by Yi-Han Lin and Matthias P. Machner (J. Cell Sci. 130, 1985–1996). ‘Cell scientist to watch – Mads Gyrd-Hansen’ (J. Cell Sci. 130, 1981–1983).

5 November 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PLPawel Leznicki
Pawel Leznicki
SHStephen High
Stephen High
The BAG6 complex was first identified as an upstream loading factor for tail-anchored membrane proteins entering the TRC40-dependent pathway for posttranslational delivery to the endoplasmic reticulum. Subsequently, BAG6 was shown to enhance the proteasomal degradation of mislocalized proteins by selectively promoting their ubiquitination. We now show that the BAG6-dependent ubiquitination of mislocalized proteins is completely reversible and identify a pivotal role for the small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) in specifically antagonizing this process. SGTA does not simply mask the exposed hydrophobic transmembrane domain of a mislocalized protein, thereby preventing BAG6 recruitment. Rather, SGTA actively promotes the deubiquitination of mislocalized proteins that are already covalently modified, thus reversing the actions of BAG6 and inhibiting its capacity to promote substrate-specific degradation. This SGTA-mediated effect is independent of its tetratricopeptide motifs, suggesting it does not require the actions of Hsp70 and Hsp90 chaperones. These data reveal that, in a cellular context, mislocalized protein ubiquitination is the result of a dynamic equilibrium reflecting competition between pathways that promote either protein maturation or degradation. The targeted perturbation of this equilibrium, achieved by increasing steady-state SGTA levels, results in a specific stabilization of a model mislocalized protein derived from the amyloid precursor protein, an effect that is completely negated by ensuring efficient precursor delivery to the endoplasmic reticulum. We speculate that a BAG6/SGTA cycle operates during protein maturation and quality control in the cytosol and that together these components dictate the fate of a specific subset of newly synthesized proteins.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
LWLydia Wunderley
Lydia Wunderley
PLPawel Leznicki
Pawel Leznicki
APAishwarya Payapilly
Aishwarya Payapilly
SHStephen High
Stephen High
Hydrophobic amino acids are normally shielded from the cytosol and their exposure is often used as an indicator of protein misfolding to enable the chaperone mediated recognition and quality control of aberrant polypeptides. Mislocalised membrane proteins, or MLPs, represent a particular challenge to cellular quality control, and in this study membrane protein fragments have been exploited to study a specialised pathway that underlies the efficient detection and proteasomal degradation of MLPs. Our data show that the BAG6 complex and SGTA compete for cytosolic MLPs via recognition of their exposed hydrophobicity, and suggest that SGTA acts to maintain these substrates in a non-ubiquitinated state. Hence, SGTA may counter the actions of BAG6 to delay the ubiquitination of specific precursors and thereby increase their opportunity for successful post-translational delivery to the endoplasmic reticulum. However, when SGTA is overexpressed the normally efficient removal of aberrant MLPs is delayed, increasing their steady state level and promoting aggregation. Our data suggest that SGTA regulates the cellular fate of a range of hydrophobic polypeptides should they become exposed to the cytosol.

1 August 2012 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
NJNicholas Johnson
Nicholas Johnson
FVFabio Vilardi
Fabio Vilardi
SLSven Lang
Sven Lang
PLPawel Leznicki
Pawel Leznicki
RZRichard Zimmermann
Richard Zimmermann
SHStephen High
Stephen High
Summary Whilst the co-translational translocation of nascent proteins across the mammalian endoplasmic reticulum (ER) is well defined, the capacity of this organelle for post-translational translocation is poorly delineated. Here we identify two human secretory protein precursors, apelin and statherin, as bona fide substrates for post-translational translocation across the ER membrane. Further studies, in combination with Hyalophora cecropia preprocecropin A (ppcecA), show that all three proteins bind to TRC40 and can utilise this component for their delivery to the ER membrane in a well-established in vitro system. However, ppcecA is not an obligate TRC40 substrate, and it can also be delivered to the ER by an alternative TRC40-independent pathway. Upon arrival at the ER membrane, these short secretory proteins appear to be ubiquitously transported across the ER membrane through the Sec61 translocon, apparently irrespective of their delivery route. We speculate that the post-translational translocation of secretory proteins in higher eukaryotes is more prevalent than previously acknowledged.